Technical Analysis for ADAP - Adaptimmune Therapeutics plc

Grade Last Price % Change Price Change
grade B 11.48 7.19% 0.77
ADAP closed up 7.19 percent on Tuesday, September 18, 2018, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ADAP trend table...

Date Alert Name Type % Chg
Sep 18 180 Bullish Setup Bullish Swing Setup 0.00%
Sep 17 Bearish Engulfing Bearish 7.19%
Sep 17 Wide Bands Range Expansion 7.19%
Sep 14 Shooting Star Candlestick Bearish 3.70%
Sep 14 Wide Bands Range Expansion 3.70%
Sep 13 Wide Bands Range Expansion 4.17%
Sep 13 Overbought Stochastic Strength 4.17%
Sep 12 Narrow Range Bar Range Contraction 2.59%
Sep 12 NR7 Range Contraction 2.59%
Sep 12 Stochastic Reached Overbought Strength 2.59%

Older signals for ADAP ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its T-cell receptor platform. Its platform enables to identify cancer targets in the form of peptides, which are short sequences of amino acids; find and genetically engineer T-cell receptors (TCR); and produce TCR therapeutic candidates for administration to patients. The company's lead product candidate includes NY-ESO, a cancer antigen, which is in Phase I/II clinical trials for the treatment of patients with solid tumors and hematological malignancies, including synovial sarcoma, multiple myeloma, melanoma, ovarian cancer, and esophageal cancer, as well as for non-small cell lung cancer. It is also developing MAGE A-10 TCR that is in preclinical stage for the treatment of breast and lung cancer, and other solid tumors, as well as a TCR therapeutic candidate directed to Alpha Fetoprotein. The company was founded in 2014 and is headquartered in Abingdon, the United Kingdom.
Is ADAP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.625
52 Week Low 6.6
Average Volume 422,555
200-Day Moving Average 10.2121
50-Day Moving Average 10.087
20-Day Moving Average 10.5735
10-Day Moving Average 11.0
Average True Range 0.6437
ADX 27.31
+DI 25.0319
-DI 16.6221
Chandelier Exit (Long, 3 ATRs ) 9.7289
Chandelier Exit (Short, 3 ATRs ) 10.1411
Upper Bollinger Band 12.1475
Lower Bollinger Band 8.9995
Percent B (%b) 0.79
BandWidth 29.772545
MACD Line 0.3701
MACD Signal Line 0.3095
MACD Histogram 0.0607
Fundamentals Value
Market Cap 1.07 Billion
Num Shares 93.5 Million
EPS -0.99
Price-to-Earnings (P/E) Ratio -11.60
Price-to-Sales 39.39
Price-to-Book 2.97
PEG Ratio 0.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.77
Resistance 3 (R3) 12.67 12.13 12.56
Resistance 2 (R2) 12.13 11.80 12.19 12.48
Resistance 1 (R1) 11.81 11.60 11.97 11.91 12.41
Pivot Point 11.27 11.27 11.36 11.33 11.27
Support 1 (S1) 10.95 10.94 11.11 11.05 10.55
Support 2 (S2) 10.41 10.74 10.47 10.48
Support 3 (S3) 10.09 10.41 10.41
Support 4 (S4) 10.19